Araştırma
Eğitim
Çözümler
Oturum Aç
TR
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Institute of Immunology
Junjian He has not added Biography.
If you are Junjian He and would like to personalize this page please email our Author Liaison for assistance.
PD-1/PD-L1 blockade restores tumor-induced COVID-19 vaccine bluntness.
Vaccine Jul, 2023 | Pubmed ID: 37400286
An oncolytic virus delivering tumor-irrelevant bystander T cell epitopes induces anti-tumor immunity and potentiates cancer immunotherapy.
Nature cancer Apr, 2024 | Pubmed ID: 38609488
Third Military Medical University
Yao Lin*,1,2,
Shuai Yue*,3,
Yang Yang*,4,
Junjian He5,
Xiaofan Yang6,
Lilin Ye5,
Xiangyu Chen7
1Department of Urology, South China Hospital, Medical School, Shenzhen University,
2Guangdong Key Laboratory for Biomedical Measurements and Ultrasound Imaging, National-Regional Key Technology Engineering Laboratory for Medical Ultrasound, School of Biomedical Engineering, Shenzhen University Medical School,
3Cancer Center, Daping Hospital & Army Medical Center of PLA, Third Military Medical University,
4Guangdong Provincial Key Laboratory of Immune Regulation and Immunotherapy, School of Laboratory Medicine and Biotechnology, Southern Medical University,
5Institute of Immunology, Third Military Medical University,
6Dermatology Hospital, Southern Medical University,
7Institute of Immunological Innovation and Translation, Chongqing Medical University
Gizlilik
Kullanım Şartları
İlkeler
Bize Ulaşın
KÜTÜPHANEYE TAVSİYE ET
JoVE HABER BÜLTENLERİ
JoVE Journal
Yöntem Koleksiyonları
JoVE Encyclopedia of Experiments
Arşiv
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Fakülte Kaynak Merkezi
Yazarlar
Kütüphaneciler
Erişim
JoVE Hakkında
Telif Hakkı © 2020 MyJove Corporation. Tüm hakları saklıdır